Skip to main content
. 2018 Mar 6;39(5):2055–2062. doi: 10.3892/or.2018.6299

Figure 1.

Figure 1.

A 71-year-old patient with locally advanced invasive ductal carcinoma (clinical stage at baseline: IIA) located in the external lower quadrant of the left breast that demonstrated pathological complete remission after neoadjuvant chemotherapy. MBI, in a mediolateral oblique view, was positive in the (A) pre-therapy study at the level of the primary tumor (arrow) while the radiotracer uptake was no longer evident in the (B) post-therapy study. MBI, molecular breast imaging.